Dacarbazine
Active substance: dacarbazine
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DACARBAZINE 200 mg/1
United StatesActive
Marketing holder: Hikma Pharmaceuticals USA Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
- DACARBAZINE · 200 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 7 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-8201-785c-be23-9dc7dc4fb9c6,01a120c3-94dc-74a1-b0a5-560fd4c6d7c4,01a120c4-389f-7b57-8dfb-2de22ddd4e26,01a120c4-dfa3-71f2-9671-a21cea086c86,01a120c6-1f34-7413-9b31-06988f281191;count=6 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-12b1-76a4-9781-dee8917ad232,01a1208e-eb15-79d9-9ccf-6d693bec911d,01a12092-2bef-79d5-87e4-079b68923ed9,01a1209b-8195-7cff-a79e-c3a10501ee5f;count=4 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 0143-9245
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
- product · openFDA NDC · 0143-9245 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0143-9245 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0143-9245 · Verified 2026-10-09 · open in source